We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AZITHROMYCIN MEDSURGE/ AZITHROMYCIN MEDICIANZ (Medsurge Pharma Pty Ltd)
Product name
AZITHROMYCIN MEDSURGE/ AZITHROMYCIN MEDICIANZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
129 (255 working days)
Active ingredients
azithromycin dihydrate
Registration type
New generic medicine
Indication
Community acquired pneumonia caused by susceptible organisms in patients who require initial intravenous (IV) therapy. In clinical studies efficacy has been demonstrated against Chlamydia pneumoniae, Haemophilus influenzae, Legionella pneumophilia, Moraxella catarrhalis, Mycoplasma pneumoniae, Staphylococcus aureus and Streptococcus pneumoniae.